Science
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station – Business Wire
LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineer
FARMINGTON, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grummans 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory. Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orbit…
-
General18 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General21 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
General23 hours agoFirst Nations children’s commissioner must have power to make change: advocates
-
Business23 hours agoHere are the 3 Australian stocks I’d tell a new investor to buy ASAP